Pfizer and GSK to battle for share of new RSV vaccine market: GlobalData
Pfizer's RSV vaccine, Abrysvo, approved by the FDA just weeks after Arexvy, is likely to show GSK significant competition
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Arexvy
US FDA approves GSK’s Arexvy, world’s first RSV vaccine for older adults
Older adults, including those with underlying medical conditions such as diabetes and chronic heart and lung disease, are at…